1 Min Read
June 22 (Reuters) - Alembic Pharmaceuticals Ltd
* Says received U.S. Food & Drug Administration (USFDA) approval for amantadine hydrochloride capsules, USP Source text - (bit.ly/2tvG8ZH) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.